Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation

Title
Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 94, Issue 8, Pages 879-883
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-09-22
DOI
10.1097/tp.0b013e3182664042

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search